Pacira BioSciences (PCRX) Shares Outstanding (Diluted) (2010 - 2026)
Pacira BioSciences (PCRX) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 833.33 Mn |
| 10 | Pacira BioSciences | 946.10 Mn | 695.07 Mn | 148.24 Mn | 40.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.30 Mn |
| Mar 31, 2026 | 40.91 Mn |
| Dec 31, 2025 | 45.04 Mn |
| Sep 30, 2025 | 44.46 Mn |
| Jun 30, 2025 | 45.46 Mn |
| Mar 31, 2025 | 46.53 Mn |
| Dec 31, 2024 | 46.25 Mn |
| Sep 30, 2024 | 46.13 Mn |
| Jun 30, 2024 | 50.54 Mn |
| Mar 31, 2024 | 52.19 Mn |
| Dec 31, 2023 | 51.98 Mn |
| Sep 30, 2023 | 52.07 Mn |
| Jun 30, 2023 | 52.05 Mn |
| Mar 31, 2023 | 45.95 Mn |
| Dec 31, 2022 | 46.54 Mn |
| Sep 30, 2022 | 45.83 Mn |
| Jun 30, 2022 | 52.48 Mn |
| Mar 31, 2022 | 46.44 Mn |
| Dec 31, 2021 | 45.63 Mn |
| Sep 30, 2021 | 45.46 Mn |